Hepatitis B and C viruses (HBV and HCV) cause chronic hepatitis and hepatocellular carcinoma (HCC) by poorly understood mechanisms. We show that cytokines lymphotoxin (LT) a and b and their receptor (LTbR) are upregulated in HBV-or HCV-induced hepatitis and HCC. Liver-specific LTab expression in mice induces liver inflammation and HCC, causally linking hepatic LT overexpression to hepatitis and HCC. Development of HCC, composed in part of A6 + oval cells, depends on lymphocytes and IKappa B kinase b expressed by hepatocytes but is independent of TNFR1. In vivo LTbR stimulation implicates hepatocytes as the major LT-responsive liver cells, and LTbR inhibition in LTab-transgenic mice with hepatitis suppresses HCC formation. Thus, sustained LT signaling represents a pathway involved in hepatitis-induced HCC.
INTRODUCTION
A causal relationship between chronic hepatitis, hepatocellular damage, fibrosis, and carcinogenesis is well established (El-Serag and Rudolph, 2007) . Various etiologies, including chronic alcohol consumption, chronic drug abuse, autoimmune disorders, toxins (e.g., aflatoxin B), or infections with hepatotropic viruses (e.g., HBV, HCV), can lead to chronic hepatitis,
SIGNIFICANCE
Pharmacological inhibition of LTbR signaling reduces pathogen-and concavalin A-induced liver injury, whereas LTbR signaling on hepatocytes appears to be beneficial during liver regeneration. We demonstrate that sustained hepatic LT expression in mice can be injurious, causing chronic hepatitis and HCC. Enhanced hepatic LTbR signaling might be of potential clinical relevance because LTbR and its ligands are drastically increased in human HBV-and HCV-induced hepatitis and HCC, compared with normal livers or nonviral, benign liver diseases. Thus, hepatic LT signaling might be advantageous if transiently active during liver regeneration, but detrimental if chronically triggered. We propose that suppression of hepatic LTbR signaling might be beneficial in liver diseases with chronic LTa, LTb, or LIGHT overexpression.
liver fibrosis, and cirrhosis. HBV and HCV infections are by far the most common cause of chronic hepatitis in humans (Malhi et al., 2006) . Chronic HBV and HCV infections are frequently associated with HCC, the most prevalent primary human liver cancer (El-Serag and Rudolph, 2007) , and except for HBV infections, liver cirrhosis precedes HCC in most cases. The exact mechanisms driving hepatitis-induced liver cancer remain elusive. Among others, aberrant expression of cytotoxic cytokines is thought to be critically involved (Greten and Karin, 2004; Lee et al., 2005; Lowes et al., 2003; Vainer et al., 2008) .
The proinflammatory and homeostatic cytokines LTa and LTb are members of the tumor necrosis factor (TNF) superfamily. Under physiological conditions, LTs are expressed by activated T-, B-, NK-, and lymphoid tissue inducer cells (Fu et al., 1998; Ware, 2005) and are crucial for organogenesis and maintenance of lymphoid tissues (Rennert et al., 1996; Tumanov et al., 2003) . Although LTb contains a transmembrane domain, LTa is soluble. Consequently, LT can exist as membrane-bound heterotrimers (LTa 1 b 2 or LTa 2 b 1 ) interacting with LTbR or as soluble secreted homotrimers (LTa 3 ) triggering TNF receptor (TNFR) 1 and TNFR2 and the herpesvirus entry mediator receptor (HVEM) (Browning et al., 1997; Ware, 2005) . LTbR and TNFR1 signaling can be activated by the HCV-core protein (Chen et al., 1997; Zhu et al., 1998) involving the canonical or noncanonical NF-kB signaling pathways (Ware, 2005; You et al., 1999) . Furthermore, HBV or HCV infections lead to increased hepatic LT expression in vivo and in vitro (Lee et al., 2005; Lowes et al., 2003) , and HCV replication has been demonstrated to depend on components of the LTbR signaling pathway in vitro (Ng et al., 2007) .
LTs can directly act on hepatocytes, which physiologically express high levels of LTbR but little LT (Browning and French, 2002) . T cell-derived LT and LIGHT (LT-like, exhibits inducible expression, competes with HSV glycoprotein D for HVEM, expressed by T-lymphocytes) signaling to hepatocytes controls lipoprotein homeostasis (Lo et al., 2007) . In addition, LT signaling is important for liver regeneration through T cell-derived LT expression (Tumanov et al., 2008) and regulates hepatic stellate cell function and wound healing (Ruddell et al., 2008) . Thus, hepatic LTbR signaling controls liver homeostasis in both health and disease.
Promotion of HCC formation by chronic inflammatory stimuli has been recapitulated in various animal models. Ablation of the multidrug resistance gene 2 (mdr2) induces cholestatic hepatitis and liver cancer (Pikarsky et al., 2004) , and administration of the chemical carcinogen diethylnitrosamine (DEN) causes acute liver injury and HCC (Maeda et al., 2005) . Liver-specific expression of the hepatitis B surface antigen (HBsAg) in mice demonstrates that chronic immune-mediated liver cell injury is critical for HCC formation (Nakamoto et al., 1998) .
Triggering TNFR1 or LTbR induces the classical and alternative NF-kB signaling pathways, which are linked to inflammation-induced carcinogenesis (Greten and Karin, 2004) . However, the precise role of these pathways in HCC pathogenesis is controversial (Vainer et al., 2008) . Mice lacking IKappa B kinase b (IKKb) specifically in hepatocytes (Ikkb Dhep ) exhibit a marked increase in DEN-induced HCC formation, suggesting a protective function of IKKb in HCC development (Maeda et al., 2005) . In contrast, NF-kB signaling promotes HCC development in mdr2 À/À mice, and anti-TNFa treatment is protective (Pikarsky et al., 2004) . Interestingly, mice with a hepatocyte-specific deletion of IKKg (also called NEMO) develop steatohepatitis and HCC (Luedde et al., 2007) . Consequently, the role of NF-kB signaling in hepatocarcinogenesis might depend on the mouse model and the type or degree of liver inflammation and injury (Vainer et al., 2008) . Here, we investigated a possible causal relationship between sustained hepatic LTbR-signaling, chronic hepatitis, and HCC development.
RESULTS
Upregulation of LTa, LTb, and LTbR in HBVor HCV-Infected Human Livers and in HCC The specific role of LT signaling in the pathogenesis of virusinduced hepatitis and HCC formation is not completely defined. We analyzed transcriptional levels of LTa, LTb, LIGHT, TNFa, LTbR, and TNFR1 in human HBV-or HCV-induced chronic hepatitis and HCC or in nonviral HCC, compared with healthy liver specimens ( Figure 1 ; Figure S1 available with this article online). LTa, LTb, and LTbR mRNA expression was increased, on average, $2 7 -to 2 10 -fold in HBV-or HCV-induced hepatitis and HCC (p < 0.001); LIGHT transcripts were less, but still significantly, elevated (on average, $2 3 -to 2 5 -fold; p < 0.001). Likewise, TNFR1 mRNA expression was significantly increased in HBV-or HCV-induced hepatitis and HCC (on average, $2 7 -to 2 9 -fold; p < 0.0001). In contrast, TNFa was only slightly upregulated in HBV-induced hepatitis (p = 0.04) but not in HCV-induced hepatitis (p = 0.3) and HCC (p = 0.4). In most cases, HCV genotype, degree of inflammation (Knodell score), fibrosis (Metavir score), and liver enzyme levels (ALT; AST) were assessed (Tables S1-S5) . Levels of LTa, LTb, and LTbR mRNA did not correlate with the degree of liver inflammation (p = 0.5), fibrosis (p = 0.5), patient age (p = 0.5), sex (p = 0.5), HCV genotype, or type of virus infection (HBV, HCV, HBV/HCV coinfection in the case of some HCC; p = 0.5) (Figure S1 ; data not shown).
To determine whether upregulation of LT ligands and receptors was specific for HBV-or HCV-induced liver diseases, we examined transcript levels in nonviral liver diseases. These included liver disorders with hepatitis (alcoholic steatohepatitis [ASH] , cholestasis [CH] , primary biliary cirrhosis/autoimmune cholangitis [PBC] , and end-stage liver cirrhosis due to alcoholic liver disease [CIR] ) and liver diseases without inflammation (steatosis [ST] and focal nodular hyperplasia [FNH] ). Additionally, other liver diseases (OLD), such as hemochromatosis/siderosis, Wilson's disease, focal liver fibrosis, a1-antitrypsin deficiency, and nonviral HCC (NVH), were investigated.
Levels of LTa, LTb, and LTbR mRNA were significantly lower in all nonviral liver diseases analyzed except NVH, compared with virus-induced chronic hepatitis and HCC (LTa, p < 0.0001; LTb, p = 0.05; LTbR, p < 0.0001; Figure 1 ; Figure S1 ). This was true whether or not nonviral liver diseases were associated with inflammation. LIGHT and TNFR1 mRNA expression in nonviral liver diseases including NVH was similar to HBV-or HCVinduced chronic hepatitis and HCC. In contrast, TNFa mRNA expression was significantly higher in nonviral liver diseases with inflammation and NVH, compared with healthy livers (p < 0.0001) or HBV-or HCV-induced hepatitis and HCC (p < 0.0001).
Increased Chemokine Expression in HBVor HCV-Induced Hepatitis and HCC To confirm that proinflammatory signaling cascades are activated during HBV-or HCV-induced hepatitis and HCC formation, chemokine mRNA levels were measured ( Figure S1 ). CCL2, CCL3, CCL5, and CXCL10 mRNA expression was significantly higher in human HBV-induced (p < 0.0001) or HCVinduced (p < 0.0001) hepatitis and HCC (p < 0.0001) than in healthy controls. CXCL1 mRNA expression was significantly increased in HBV-induced hepatitis (p < 0.0001) and HCC (p = 0.02), but not in HCV-induced hepatitis (p = 0.07).
Upregulation of LTa, LTb, and LIGHT in Human Hepatoyctes upon HCV Infection In Vitro We next investigated whether LTa, LTb, LIGHT, and LTbR transcripts can be upregulated in hepatocytes as a consequence of viral infection. The human hepatocyte cell line Huh-7.5 (Blight et al., 2002) was challenged with infectious HCVcc (Pietschmann et al., 2006) , and the expression of cytokines and chemokines was measured ( Figure S2A ). At 48-72 hr after infection, transcripts of LTa (p = 0.05), LTb (p = 0.05), LIGHT (p = 0.05), LTbR (p = 0.05), and chemokines (CCL2, CCL3, CXCL1, and CXCL10) were increased (2-to 32-fold) in HCVcc-infected, compared with noninfected Huh-7.5 cells.
Identification of Liver Cells Expressing LTbR and Its Ligands in HBV or HCV Infections
To identify the cellular source of LTa, LTb, LTbR, and LIGHT expression in human HCV-infected livers, cells were collected from HCV-induced hepatitis and HCC (Figure 2A ; Figure S2B ). Liver cells were sorted according to their CD45 surface expression, resulting in CD45-enriched (T and B cells; monocytes, macrophages, and Kupffer cells; and dendritic and NK cells) or CD45-depleted (hepatocytes, oval cells, and bile duct epithelial and endothelial cells) fractions. Purity of these fractions was assessed by real-time PCR for lymphocyte (CD3, CD20, and CD45) or hepatocyte (cytokeratin 18) markers. CD45-depleted fractions displayed only a minor contamination with CD45 mRNA ($1%-10%), and CD45-enriched fractions showed only a minor amount of cytokeratin 18 mRNA transcripts ($2%-20%; Figure S2C ; data not shown). Unsorted liver cells of healthy individuals were included as controls. Because of ethical Analysis of hepatic LTa, LTb, LTbR, LIGHT, TNFR1, and TNFa transcription by real-time PCR. Healthy individuals (Ctrl; n = 15), patients chronically infected with HBV (n = 19) or HCV (n = 49), affected by HCC (n = 30), or suffering from various non-virus-related liver disorders were investigated. Non-virus-related liver diseases with hepatitis include alcoholic steatohepatitis (ASH; n = 13), cholestasis (CH; n = 3), primary biliary cirrhosis/autoimmune cholangitis (PBC; n = 5), end-stage liver cirrhosis due to alcoholic liver disease (CIR; n = 8), a1-antitrypsin deficiency (a1AT; n = 1), and focal liver fibrosis (FLF; n = 2). Non-virus-related liver diseases without hepatitis include steatosis (ST; n = 5), hemochromatosis/siderosis (HE/SID; n = 3), and Wilson's disease (WD; n = 1). Focal nodular hyperplasia (FNH; n = 8) was investigated as a benign primary liver tumor. Diseases such as a1AT (black circles), FLF (black triangles), HE/SID (black diamonds), and WD (white diamonds) are listed under ''other liver diseases'' (OLD). Horizontal bars represent the average mRNA expression level. The y axis describes the DDCT values on a log 2 scale. Asterisks indicate statistical significance: *p % 0.05; **p < 0.001; ***p < 0.0001. consideration, not enough human healthy liver tissue was available in order to perform cell sorting.
Within HCV-induced HCC, CD45-enriched and -depleted liver cells expressed similar LTa or LTb mRNA levels (LTa, p = 0.8; LTb, p = 0.1) that were significantly higher than in controls (p < 0.0001) (Figure 2A ). LTbR mRNA transcript levels were significantly higher in CD45-depleted cells, compared with Immunohistochemical analysis for LTb protein expression corroborated these data: CD3 + and CD20 + lymphocytes and hepatocytes in HBV-or HCV-induced hepatitis and HCC, but not those in healthy liver specimens, express LTb protein ( Figure 2C ).
Hepatocyte-Specific LTa and -b Overexpression Induces Chronic Progressive Hepatitis
To determine whether sustained hepatic LTbR signaling is causally linked to chronic hepatitis and liver cancer, we analyzed two transgenic mouse lines that expressed LTa and -b in a liverspecific manner at low (tg1222) or high (tg1223) level (Heikenwalder et al., 2005) . Although livers of tg1222 and tg1223 mice were histologically indistinguishable from those of control littermates at three months of age ( Figure S3 ), the hepatic transcriptome was already considerably altered in tg1223 and to a lesser degree in tg1222 mice ( Figure 3A ; data not shown). Genes with the most dramatic expression changes were identified by DNAmicroarray analysis and confirmed by real-time PCR ( Figure 3A ). As expected, Lta and Ltb transcripts were increased in tg1222 and tg1223 livers ( Figure 3A ; data not shown). Additionally, mRNA expression of chemokines (Ccl2, Ccl7, Cxcl1, and Cxcl10), genes involved in early growth response (e.g., Egr1 and Egr2), cholesterol metabolism (e.g., Ch25h), and immediate early response (e.g., c-Fos, Jun-b, and Socs-3) were significantly (p < 0.0001) elevated. In contrast, genes involved in cell cycle control, histone modifications, and cell metabolism were significantly downregulated (p < 0.0001) ( Figure 3A ; Tables S6-S8 and Figure S4 ). In situ hybridization revealed Lta, Ltb, Cxcl10, Ccl2, and Egr1 mRNA transcripts in hepatocytes of 3-month-old tg1223 mice ( Figure 3B ; Figure S3 ).
At the age of 4 months, a slight increase in intrahepatic CD11b + , CD68 + , and MHCII + cells was detected in tg1223 mice, compared with age-matched tg1222 or C57BL/6 mice (Figure S3 ; data not shown). At this time point, no significant increase in IL1b, IFNg, IL6, and TNFa protein levels was found (data not shown). At 4-6 months, transgenic livers started to develop strong portal and lobular (tg1223) or weak portal (tg1222) inflammation consisting of CD4 + , CD8 + T cells, B220 + B cells, and CD11c + dendritic cells ( Figure S3 ; Heikenwalder et al., 2005) .
At R9 months of age, tg1223 livers exhibited strong portal and lobular lymphocytic infiltrates ( Figure 3C section; C57BL/6, 0.5 ± 0.3 Ki67 + cells/mm 2 liver section; p = 0.003), which was not significant in age-matched tg1222 livers (p = 0.08; Figure 3C ; data not shown).
At this stage, hepatitis was accompanied by increased protein levels of IL1b (p = 0.05), IFNg (p = 0.05), and IL6 (p = 0.05), and, to a lesser degree, TNFa in tg1223 livers. In tg1222 livers, we observed only a slight elevation of these cytokines, compared 
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Sustained Hepatic LT Signaling Causes HCC with C57BL/6 ( Figure 3D ). Quantitative analysis of total intrahepatic lymphocytes revealed an increase in tg1223 livers (C57BL/6, 17-24 3 10 6 cells/liver; tg1223, 35-73 3 10 6 cells/liver; p < 0.05). Intrahepatic lymphocytes were further characterized by flow cytometry ( Figure 3E ). Frequencies of CD8 + (C57BL/6, 18% ± 11%; tg1223, 38% ± 10%), CD4
+ (C57BL/6, 16% ± 3%;
tg1223, 26% ± 6%) and TCRb + T cells (C57BL/6, 33.5% ± 9%; tg1223, 63.5% ± 4%) were elevated (n = 4), whereas NK1.1 + cells (C57BL/6, 12% ± 2%; tg1223, 7% ± 2%) were reduced in tg1223 livers. Furthermore, an increase in the frequency of CD19 + B cells was found in tg1223 livers (C57BL/6, 25% ± 7%; tg1223, 52% ± 4%). Elevated frequencies of IFNg-producing CD4 + and CD8 + T cells were found in tg1223 mice, whereas IL17-producing cells remained unchanged ( Figure 3E ; data not shown).
LTa and LTb Overexpression Induces Hepatotoxicity
To determine whether chronic hepatitis leads to hepatocyte cell death in tg1222 or tg1223 mice, we analyzed serum transaminase levels (ALT and AST). From the age of 19 weeks on, serum ALT and AST levels were significantly elevated (p = 0.05) in tg1223, but not in tg1222 mice ( Figure 4A ), and apoptotic hepatocytes were frequently detected in tg1223 mice (tg1223, 40.3 ± 11.4 TUNEL + cells/mm 2 liver section; C57BL/6, 3.9 ± 6.2 TUNEL + cells/mm 2 liver section; p = 0.0005), but rarely in tg1222 and virtually absent in C57BL/6 mouse livers from the age of 6 months on ( Figure 4B ; Figure S5 ; data not shown for tg1222). Hepatitis persisted in both transgenic lines for R18 months. Phenotypes were much milder in tg1222 mice, implying that the LT expression level determined the severity of inflammation and liver injury. Therefore, tg1223 mice were selected for additional experiments, and further key results were obtained from this mouse line.
Microarray and real-time PCR analyses revealed elevated mRNA expression of genes involved in embryogenesis (e.g., Dmrta1), liver inflammation (e.g., Pbfe1), carcinogenesis (e.g., Phlda3 and Thrsp; Kawase et al., 2009) , glucose homeostasis and insulin sensitivity (e.g., Fgf21), and reduced mRNA expression of genes responsible for cell-cycle control (Gadd45 g) and protease inhibition (SerpinA9) in 9-month-old tg1223 livers, compared with C57BL/6 livers ( Figure S5 and Tables S9-S11). Several genes were strongly up-or downregulated in 3-monthold tg1223 livers ( Figure 3A ) and returned to normal levels at 9 months, except that Lta and -b mRNAs remained at high levels. On the other hand, genes involved in cell division, liver inflammation, lipid metabolism, wound healing, and tumorigenesis were significantly upregulated (p < 0.001), whereas genes involved in growth arrest and apoptosis were significantly downregulated (p < 0.001) in 9-month-old compared with 3-month-old tg1223 livers ( Figure S5 ; Tables S12-S17).
HCC Development in tg1223 Mice
At 12 months of age, about 20% (6/34) of tg1223 mice developed macroscopically visible nodules that classified histologically as HCC, including broadening of liver cell cords, loss of collagen IV networks, and increased proliferative activity. In contrast, age-matched C57BL/6 livers lacked HCC (0/20; p = 0.05) (Figures 4C, 4D , and 5). Tumor frequency increased with age, reaching $35% (18/51) by 18 months, whereas C57BL/6 mice did not develop HCC (0/35; p < 0.0001) ( Figure 5 ; Figure S6 ). Tumors varied in size (1-25 mm), and histology and affected both sexes with similar frequencies (males:females = 13:11; p = 0.3) (Figure 4 ; Tables S18 and S19). A6 + oval cells (Engelhardt et al., 1990) were focally (8/24) or diffusely (2/24) distributed within some tg1223 HCC. The remaining tg1223 HCC (14/24) lacked A6 + cells but were surrounded by them at the border zone of HCC ( Figure S6 ).
Chromosomal Aberrations and Local Spread of HCC in tg1223 Mice
We further investigated microdissected tg1223 HCC (n = 9) and age-matched C57BL/6 livers (n = 5) for chromosomal aberrations. Array comparative genomic hybridization analysis (aCGH) revealed chromosomal aberrations in all tg1223 HCC (Figure 6 ). Amplifications and deletions of chromosomal regions ranged from %1 megabase (MB) to 160 MB and were detected in most autosomes of all analyzed tg1223 HCC. Of note, the pattern of chromosomal aberrations varied in HCC from different individual tg1223 mice (p = 0.34). aCGH analysis of independent C57BL/6 liver DNA samples did not reveal significant chromosomal aberrations.
We did not detect lung metastases but often saw multifocal intrahepatic disease in 18-month-old tg1223 mice. We therefore investigated whether multifocal tg1223 HCC represented intrahepatic spread of clonal tumors. Independent HCC (n = 6) from different lobes of the same tg1223 liver were microdissected and subsequently analyzed by aCGH. All HCC taken from the same liver displayed significantly overlapping chromosomal aberrations throughout the entire genome (p < 0.05), suggesting a clonal relationship of a tumor that has locally spread within the liver ( Figure 6B ).
Expression of Tumor Markers GP73, GS, and AFP in tg1223 HCC
We then evaluated expression of human liver tumor markers golgi protein 73 (GP73), glutamine synthetase (GS), and a-fetoprotein (AFP) in tg1223 livers (Bachert et al., 2007; Marrero and Lok, 2004; Sakamoto, 2009 ). GP73, GS, and AFP protein expression was elevated in most tg1223 HCC, as detected by immunohistochemistry and immunoblot analysis, compared with C57BL/6 livers or unaffected liver regions adjacent to HCC (Figures 7A-7C ; data not shown).
Mechanisms Driving LTab-Induced Chronic Hepatitis and Liver Cancer
To identify other receptors and molecular mediators potentially involved in LT-induced chronic hepatitis and HCC development, we intercrossed tg1223 with Tnfr1
Dhep mice. The requirement of lymphocytes in chronic hepatitis and HCC formation was investigated by intercrossing with Rag1 À/À mice, which lack mature lymphocytes.
The absence of IKKb, TNFR1, or lymphocytes per se did not appear to influence transgenic Lta and -b mRNA expression ( Figures 3A and 7D) Figure 7D ; Figure S7 ). At 9 months of age, tg1223/Rag1 À/À (n = 26) and tg1223/Ikkb Dhep (n = 18) livers lacked hepatitis, hepatocyte, or oval-cell proliferation ( Figure S4 ), whereas tg1223/Tnfr1 À/À (n = 8) or tg1223/Tnfr2 À/À (n = 8) livers were indistinguishable from those of tg1223 mice ( Figure 3C and Figures 7E and 7F; Figure S7 ). At the age of 18 months, tg1223/Rag1 À/À (n = 26) and tg1223/ Ikkb Dhep (n = 25) mice were devoid of hepatitis and HCC (p < 0.0001) (Figures 5 and 7G ), suggesting that both lymphocytes and hepatocyte-specific IKKb expression are required for LT-induced chronic hepatitis and HCC development. Notably, tg1223/Tnfr1 À/À mice displayed HCC (4/12) with an incidence similar to that among tg1223 mice (Figures 5 and 7G ; Figure S8 ; Tables S18 and S19), indicating that TNFR1 signaling is not essential for LT-induced HCC formation in tg1223 mice.
Hepatocytes Are the Major Responsive Liver Cells to Agonistic LTbR Antibody Treatment
To investigate whether hepatocytes represent the major LTresponsive liver cells and to investigate LTbR signaling in Tnfr1 À/À and Ikkb Dhep livers, TNFa (positive control), agonistic LTbR antibody (3C8), and appropriate negative controls (PBS; rat IgG) were administered intravenously to C57BL/6 and various knockout mice (Figure 8 ; Figure S8 ). Nuclear p65 (RelA) translocation in hepatocytes and nonparenchymal cells (NPC, e.g., Kupffer cells and lymphocytes), alterations in the hepatic transcriptome, and protein expression of selected chemokines were examined.
Administration of 3C8 induced nuclear p65 translocation, primarily in hepatocytes and some NPC of C57BL/6 livers ( Figure 8A ), as well as transcriptional changes and upregulation of selected chemokines reminiscent of those observed in 3-month-old tg1223 livers ( Figure 8A ; Figure S9 ). Similar results were obtained after 3C8 treatment of Tnfr1 À/À mice, in contrast to Ikkb Dhep livers, which were devoid of nuclear p65 translocation in hepatocytes and NPC (Tables S20 and S21 ). Furthermore, upregulation of selected NF-kB target genes could not be detected. Control Ltbr À/À mice treated with 3C8 lacked nuclear p65 translocation in hepatocytes or NPC, as well as upregulation of selected NF-kB target genes.
To examine whether lack of functional IKKa on hepatocytes and NPC would suppress LTbR-induced upregulation of selected NF-kB responsive genes, we investigated livers of mice expressing a nonphosphorylatable IKKa AA knockin allele (Ikka AA/AA ; Cao et al., 2001) . Upon 3C8 treatment, Ikka AA/AA mice upregulated selected NF-kB responsive genes ( Figure S8 ). The degree of mRNA upregulation in liver was similar to that in 3C8-treated C57BL/6 mice. In contrast, control treated (rat IgG) Ikka AA/AA mice lacked upregulation of selected NF-kB responsive genes. This finding suggests that 3C8-mediated hepatic LTbR signaling is mainly integrated by hepatocytes involving canonical NF-kB pathway.
Inhibition of LTbR Signaling Reduces Chronic Hepatitis and Carcinogenesis
We further investigated the involvement of LTbR signaling in the transition of chronic hepatitis to HCC by long-term LTbR-Ig administration in tg1223 mice. Nine-month-old tg1223 mice with chronic hepatitis (n = 31) or age-matched C57BL/6 mice (n = 23) were treated with LTbR-Ig for 2 months, remained untreated for another 4 weeks, and then were sacrificed. LTbR-Ig treatment significantly reduced chronic hepatitis incidence in tg1223 mice, compared with that in untreated tg1223 mice (treated, 4/31; untreated, 34/34; p < 0.0001) . Furthermore, LTbR-Ig treatment suppressed chronic hepatitis-driven HCC formation (treated, 0/31; untreated, 6/34; p < 0.05) (Figures 5  and 8B ). LTbR-Ig treatment did not lead to overt histopathological alterations in C57BL/6 livers or overt changes in lymphocyte (B and T cells) or macrophage populations within spleens of C57BL/6 or tg1223 mice (data not shown). Efficiency of LTbR-Ig treatment was ascertained by the loss of LTbR-dependent follicular dendritic cells (FDCs) within C57BL/6 and tg1223 spleens ( Figure S9 ). Thus, our results imply that long-term suppression of LTbR reduces chronic hepatitis incidence and can prevent the transition from chronic hepatitis to HCC in tg1223 mice.
DISCUSSION
This study uncovered drastic and robust mRNA upregulation of LTbR, LTa, and LTb in HBV-or HCV-induced hepatitis and HCC. LT and LIGHT transcripts were mainly expressed by CD3 + T cells and CD20 + B cells; a significant proportion of LTa and LTb expression was also attributable to hepatocytes. Notably, upregulation of LTbR, LTa, and LTb transcripts was also detected in non-virus-related HCC, which could stem from activated, tumor-infiltrating lymphocytes and/or from neoplastic hepatocytes that have upregulated LT, possibly in response to IL6. It was demonstrated that HCC-derived cell lines express IL6 (Baffet et al., 1991) and that LT levels are increased in response to IL6 in the latter (Subrata et al., 2005) .
LT signaling induces both canonical and noncanonical NF-kB signaling pathways, whose role in controlling liver cancer formation remains controversial (Vainer et al., 2008) . In a mouse model with acute DEN exposure, depletion of functional NF-kB signaling (Ikkb Dhep mice) increased hepatocyte cell death, enhanced Kupffer cell activation, and elevated HCC incidence (Maeda et al., 2005) . In contrast, NF-kB signaling promotes HCC development in mdr2 À/À mice (Pikarsky et al., 2004) , and hepato- We propose that, rather than directly acting as a cell-autonomous oncogene on hepatocytes or A6 + oval cells, hepatic LTab expression induces local upregulation of chemokines (e.g., Ccl2, Cxcl10, Cxcl1, and Ccl7) by hepatocytes. This leads to the attraction of circulating inflammatory cells and a hyperproliferative, hepatotoxic environment stochastically leading to HCC formation ( Figure 8C ). It is worth mentioning that some chemokines found in this study (e.g., CXCL10) have been reported to be mainly expressed by human hepatocytes in chronic hepatitis C (Zeremski et al., 2007) .
Ablation of TNFR1 signaling did not prevent chronic hepatitis and HCC formation in tg1223 mice, although anti-TNFa antibody treatment prevents HCC development in mdr2 À/À mice (Pikarsky et al., 2004) . We investigated the mode of LT signaling in Tnfr1
livers upon 3C8 treatment. This treatment induced analogous hepatic changes seen in tg1223 mice at 3 months of age. Similar to our results with tg1223/Tnfr1 À/À mice, this finding suggests that heterotrimeric LT causes p65 translocation in hepatocytes and induces a TNFR1-independent signaling cascade via LTbR, presumably contributing to chronic hepatitis and HCC. Most probably, HCC formation in mdr2 À/À mice depends on pathways involving TNFR1 distinct from the LTbR-dependent pathways described in our study.
Intravenous administration of TNFa into Ikkb
Dhep mice did not cause p65 translocation in hepatocytes but upregulated NF-kB target genes, presumably through TNFa-activated NPC. In contrast, 3C8 treatment in Ikkb Dhep mice had no effect. Therefore, hepatocytes but not NPC are likely to be the major liver cells integrating LT signaling. Interestingly, upon 3C8 treatment, Ikka AA/AA livers upregulated selected NF-kB target genes, similar to C57BL/6 mice ( Figure S8) . Therefore, the absence of IKKa in hepatocytes and NPC allows NF-kB target gene expression upon 3C8 treatment, suggesting the involvement of the classical NF-kB pathway in LTbR-induced hepatic signaling.
LTbR signaling was reported to induce oval-cell proliferation (Akhurst et al., 2005) , which is thought to contribute to the development of liver tumors (Lee et al., 2006) . We observed proliferation of A6 + oval cells in chronically inflamed tg1223 livers at the age of 9 months and found A6 + cells within and at the border of tg1223 HCC. Whether those A6 + cells represent transformed oval cells contributing to liver carcinogenesis or whether A6 is upregulated on aberrant hepatocytes within HCC remains to be determined. Lack of lymphocytes or chronic hepatitis prevented oval-cell proliferation, although LTa and b transgene expression was unaltered. Therefore, it is conceivable that activated, infiltrating lymphocytes or Kupffer cells may contribute to oval cell proliferation by providing further LT or other cytokines in tg1223 livers. On the basis of the presented data, a sequence of events leading to chronic hepatitis and HCC in tg1223 mice can be proposed ( Figure 8C) .
What are the possible clinical implications of our findings? It has recently been demonstrated that pharmacological inhibition of LTbR signaling reduces virus-, bacteria-, and concavalin A-induced liver injury Anand et al., 2006; Puglielli et al., 1999) , whereas triggering LTbR signaling on hepatocytes appears to be beneficial during liver regeneration (Tumanov et al., 2008) . Moreover, siRNA knock-down of various components of the LTbR signaling pathway (e.g., LTb and RelA) were shown to interfere with HCV replication in vitro (Ng et al., 2007) . Therefore, inhibition of LTbR signaling might also impede the efficiency of HCV replication.
What are the possible side effects of blocking LTbR signaling? The reported effects include alterations in the microarchitecture of white pulp follicles and disappearance of FDC networks in nonhuman primates (Gommerman et al., 2002) . Of note, despite the loss of FDCs and a reduced capacity to trap immune complexes, the primary antibody response to keyhole limpet hemocyanin was not significantly altered (Gommerman et al., 2002) . Accordingly, we have investigated a possible beneficial effect of blocking LTbR signaling in tg1223 mice with chronic hepatitis. This partially reverted inflammation and prevented HCC formation, suggesting that LTbR-Ig treatment might be beneficial in liver pathologies with sustained LT signaling.
Our results show that LT signaling is critically involved in hepatitis and subsequent HCC development and imply that blocking LTbR signaling might become a beneficial therapeutic approach in the context of HBV-or HCV-induced chronic hepatitis and other liver diseases displaying sustained hepatic LTbR signaling.
EXPERIMENTAL PROCEDURES Human Liver Tissue
Human liver biopsy specimens were obtained from University Hospitals Zurich, Freiburg, Grenoble, Heidelberg, and Graz. Biopsy specimens were registered in the respective biobanks and kept anonymous. , Ikka AA/AA , and Ikkb Dhep mice were generated as previously published (Bluethmann et al., 1994; Cao et al., 2001; Futterer et al., 1998; Heikenwalder et al., 2005; Maeda et al., 2005; Mombaerts et al., 1992) .
TNFa and 3C8 Treatment
Twelve-to-fourteen-week-old male mice (C57BL/6 and knock-out mice) were intravenously injected with either PBS, murine recombinant TNFa (50 mg/kg bodyweight; R&D Systems), agonistic LTbR antibody (50 mg/mouse; clone 3C8; eBioscience), or rat IgG (50 mg/mouse; eBioscience) and sacrificed for analysis 45 min after injection. All substances were injected at a total volume of 100 ml dissolved in PBS.
Isolation of Intrahepatic Murine Lymphocytes
Mice were anesthetized, and liver was perfused with PBS to remove circulating leukocytes; then isolated liver tissue was minced and digested in medium containing collagenase (1 mg/ml) and DNase (25 mg/ml) at 37 C for 40 min. Cells were centrifuged at 300 rpm for 3 min to sediment the majority of hepatocytes. Supernatant was removed and centrifuged again at 1200 rpm for 10 min. Cell pellet was resuspended in the 40% fraction of a 40:80 Percoll gradient. Upon centrifugation at 2500 rpm for 20 min, intrahepatic murine lymphocytes (IHLs) were collected at the interface. IHLs were analyzed for surface marker expression by staining with anti-CD4, anti-CD8, anti-TCR-b, anti-NK1.1, or anti-CD19 antibodies (Abs), and for cytokine production capacity by intracellular staining with anti-IFNg and anti-IL17 Abs (all from eBioscience) upon PMA/Ionomycin stimulation for 4 hr by using a two-laser FACScalibur (BD). Analysis was executed with CellQuest and FlowJo software.
Measurement of Aminotransferases
The analysis for AST and ALT was performed with mouse serum on a Roche Modular System (Roche Diagnostics) with a commercially available automated colorimetric system at the Institute of Clinical Chemistry at the University Hospital Zurich using a Hitachi P-Modul (Roche).
ACCESSION NUMBERS
Gene expression microarray data are deposited in the ArrayExpress database under accession number E-MEXP-1998. aCGH data are deposited in the GEO database under accession number GSE 14467.
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